The main channels {#s1}
=================

The main international channels of professional update in the mental health field are scientific meetings, traditional publications (i.e. professional journals, books and other printed materials), the internet and the direct channels used by drug companies.

Scientific meetings {#s2}
-------------------

A well-organised international meeting offers a variety of opportunities for update, from state-of-the-art lectures to workshops and educational courses. Several international meetings offer a programme of continuing medical education (CME) courses, with provision of credits.

The problem is, however, that the average European psychiatrist is often unable to afford the registration fee, so that his or her participation often depends on sponsorship by a drug company. This means that psychiatrists who do not have relationships with drug companies are penalised in their access to professionally relevant information. This is the case for virtually all psychiatrists of some European countries which are not very attractive to drug companies, in particular in eastern Europe. For instance, during the AEP CME course held in Almaty, Kazakhstan, on 6 June 2003, the participants were asked to complete a questionnaire concerning their previous participation in international psychiatric congresses. Out of the 56 participants on the course, who were likely to represent a selected group of highly motivated psychiatrists, only two had ever participated in a World Congress of Psychiatry, and none had ever attended a Congress of the AEP, the European College of Neuropsychopharmacology (ECNP), the Collegium Internationale Neuropsychopharmacologicum (CINP) or the American Psychiatric Association (APA). For those who may think that this is a marginal problem, it is useful to point out that the number of psychiatrists who are currently active in Kazakhstan is about 1000.

> For contributions to the Associations and Collaborations column, please contact Dr John Henderson: <john.henderson53@btopenworld.com>

The European audience of international psychiatric meetings is represented by a restricted elite, mostly consisting of psychiatrists from 'group A' countries of the World Bank classification (i.e. those with the highest income per capita). Moreover, the participation of European mental health professionals other than psychiatrists is usually very limited.

> The European audience of international psychiatric meetings is represented by a restricted elite.

Traditional publications {#s3}
------------------------

In psychiatry and related mental health disciplines, there are presently 89 journals for which the Institute of Scientific Information reports an impact factor, of which 76 are produced in English. Most of these journals have an international distribution, but the vast majority and sometimes the totality of their subscribers are from North America, Western Europe and Australia. The average European psychiatrist (especially from a group B, C or D country) cannot afford the cost of the subscription to even one international journal. Moreover, in many European countries, libraries where international psychiatric journals can be found are few and difficult to access; in several group C or D European countries, no such library is available. Furthermore, many academic centres, even in group A European countries, are currently reducing the number of journals to which they subscribe.

Financial and logistic difficulties are not the only obstacles to the access of European psychiatrists to international journals. Many European clinicians, even if they are able to read English (which is not the case for several thousands of psychiatrists in Europe), experience increasing difficulties in understanding the technical details of some papers published in international journals -- indeed, the contents of some international journals are becoming less and less accessible to clinicians.

Finally, few clinical psychologists and other mental health professionals have access to international mental health journals in most European countries.

The offer of books in the mental health field is rich and varied. However, access to books is even more limited than to journals. The cost of books is often prohibitive for the vast majority of professionals. Even many academic centres in group B, C or D European countries cannot afford to purchase them. Access to individual chapters of published books is much more difficult than to papers published in international journals. This is one of the reasons why books are increasingly becoming a vehicle for theoretical essays or reviews of the literature rather than for new information.

> What should be the role of international professional associations? Can they do more than organise scientific meetings for a small minority of European psychiatrists, or publish journals and books for an even more limited audience, or make attempts to harmonise national CME programmes (which in several cases exist only on paper)?

It is useful to emphasise that the majority of international psychiatric journals largely depend for their survival on advertisements by drug companies, and that many publishing companies require the author of a book to ensure that a certain number of copies be purchased by a sponsor, which is usually a drug company.

The internet {#s4}
------------

The role of the internet in the dissemination of information in the mental health field is becoming more and more significant. The main problem with this information is its very varied quality and credibility. International professional associations have a very important role to play here, not only by providing information and educational materials on their own websites, but also by developing rules with which their members have to comply in the provision of information, as well as a system of accreditation of the information which appears on-line, as a guide for users.

The drug companies {#s5}
------------------

Besides funding, directly or indirectly, the majority of the above-mentioned channels by which information is disseminated in the mental health field, drug companies are increasingly developing their own, direct channels. In addition to traditional leaflets focusing on their products, they often distribute proceedings of symposia they have sponsored, reprints of articles published in international journals and other printed materials. Moreover, several companies now invite internationally renowned researchers with whom they have good relationships to deliver seminars in several centres, with the participation of many hundreds of psychiatrists, including many who do not usually attend international scientific meetings.

The role of international professional associations {#s6}
===================================================

In this situation, what should be the role of international professional associations? Can they do more than organise scientific meetings for a small minority of European psychiatrists, or publish journals and books for an even more limited audience, or make attempts to harmonise national CME programmes (which in several cases exist only on paper)? Can these associations do more for psychiatrists of those European countries which are currently almost forgotten by the international psychiatric community? I believe that not only can they do so, but they have the duty to do so, and that the crucial step is the establishment of a close collaboration with national psychiatric societies. These societies should be provided not only with rules and guidelines, but also with concrete support, for example in the form of internationally renowned teachers and high-quality educational materials, following their own priorities rather than those of any sponsor or of any European body.

The AEP programme of itinerant CME courses ([Table 1](#t1){ref-type="table"}) represents a first step in this direction. Our starting point has been the programme of CME courses delivered at the 11th Congress of the Association in Stockholm in May 2002. This programme included 36 CME courses, all developed under the guidance of an ad hoc committee. These courses were formally evaluated in Stockholm by three groups of assessors: the participants, the teachers and a group of observers appointed by the AEP and the host society, the Swedish Psychiatric Association. Among the courses which received the best ratings, the AEP Executive Committee selected those whose topics were most likely to be of interest to psychiatrists of all the various European countries. The list was then submitted to the presidents of all national psychiatric societies, asking them to host one or more of the courses within their national congresses, as a joint initiative of their society and the AEP, providing the same kind of evaluation which took place in Stockholm. Local expenses, including those of simultaneous translation, were to be covered by national societies, whereas the travel expenses and the honoraria for the teachers were to be covered by the AEP. No drug company was to be involved in any way in the organisation of the courses.

###### Calendar of AEP itinerant CME courses for the second half of the year 2003

  Date              Location             Collaborating body                                          Title                                                                                       Director(s)
  ----------------- -------------------- ----------------------------------------------------------- ------------------------------------------------------------------------------------------- ----------------------------------------
  2 June            Tel Aviv, Israel     Israeli Psychiatric Association                             How to set up and evaluate a community mental health service                                G. Thornicroft, UK
  6 June            Almaty, Kazakhstan   Kazakh Association of Psychiatrists and Narcologists        Trends in drug treatment of schizophrenia                                                   F.-A. Wiesel, Sweden
  11 June           Oviedo, Spain        Spanish Association of Neuropsychiatry                      How to set up and evaluate a community mental health service                                G. Thornicroft, UK; M. Tansella, Italy
  13 August         Reykjavik, Iceland   Icelandic Psychiatric Association                           Cognitive--behavioural therapy in anxiety disorders                                         L.-G. Ost, Sweden
  8 September       Tblisi, Georgia      Society of Georgian Psychiatrists                           ADHD through the life span                                                                  S. Tyano, Israel
  15 October        Antalya, Turkey      Psychiatric Association of Turkey                           Alcohol dependence                                                                          K. Mann, Gernmany
  20 October        Bologna, Italy       Italian Psychiatric Association                             Liaison psychiatry: identifying and treating psychiatric problems in a medical population   F. Creed, UK
  19--23 November   Berlin, Germany      German Society of Psychiatry, Psychotherapy and Neurology   Teaching general practitioners about depression                                             J. Cooper, UK
                                                                                                     Alcohol dependence                                                                          K. Mann, Germany

To date, concrete agreements have been made with 18 national psychiatric societies for the co-organisation of the courses (the Czech Psychiatric Society; the Danish Psychiatric Association; the Finnish Psychiatric Association; the German Society of Psychiatry, Psychotherapy and Neurology; the Icelandic Psychiatric Association; the Israeli Psychiatric Association; the Italian Psychiatric Association; the Kazakh Association of Psychiatrists and Narcologists; the Kyrgyz Psychiatric Association; the Lithuanian Psychiatric Association; the Luxembourg Society of Psychiatry, Neurology and Psychotherapy; the Maltese Psychiatric Association; the Polish Psychiatric Association; the Portuguese Psychiatric Association; the Psychiatric Association of Slovenia; the Psychiatric Association of Turkey; the Society of Georgian Psychiatrists; the Spanish Association of Neuropsychiatry). The list of the courses scheduled for the second half of the year 2003 is presented in [Table 1](#t1){ref-type="table"}.

Of course, this is just a beginning, and many things can be done to extend the initiative in terms of countries involved, of courses provided, and of participants in each country. However, several principles on which the initiative is based deserve attention:

-   the collaboration of an international psychiatric association with national psychiatric societies in Europe in a concrete educational activity

-   the implementation of the initiative in individual European countries

-   the coverage of all areas of Europe, without exclusion;

-   the possibility offered to national societies to choose the topics and teachers of interest

-   the coverage of part of the expenses by the international association

-   the decision not to request the sponsorship of a specific drug company.

> What we are especially exploring, however, is the possibility to submit to the European Union a comprehensive European educational programme.

In the future, the possibility may be considered of building up a consortium of drug companies covering part of the costs of the initiative. This consortium should not have any role in the selection of the topics, the teachers, or the countries in which the courses have to be implemented. What we are especially exploring, however, is the possibility to submit to the European Union a comprehensive European educational programme, jointly promoted by the AEP, the European Region of the World Psychiatric Association, the European Union of Medical Specialists and the European region of the World Health Organization, in collaboration with national psychiatric societies in Europe.
